Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 5;20(1):117.
doi: 10.1186/s12933-021-01309-3.

Effect of renal denervation on long-term outcomes in patients with resistant hypertension

Bo Liang  1 , Yi Liang  2 , Rui Li  1 , Ning Gu  3
Affiliations
Review

Effect of renal denervation on long-term outcomes in patients with resistant hypertension

Bo Liang et al. Cardiovasc Diabetol. .

Abstract

Increasing studies strongly prove that renal denervation, a minimally invasive surgery, is a promising new non-drug treatment method that can effectively control blood pressure in patients with resistant hypertension, but the evaluation of the long-term blood pressure control effect of renal denervation for resistant hypertension is still lacking. Here, we critically review current long-term follow-up data about the use of renal denervation for RH to comprehensively evaluate the effectiveness of renal denervation for RH, and to provide practical guidance for practitioners who are establishing a renal denervation service. Limited by the current research, many problems need to be solved before renal denervation is applied to RH. In addition, ambulatory blood pressure should be the first choice for the evaluation of blood pressure. Finally, the continuous antihypertensive effect of renal denervation in different renal denervation systems also needs to be strictly compared.

Keywords: Hypertension; Intervention; Renal denervation; Resistant hypertension.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Effect of renal denervation on long-term outcomes in patients with resistant hypertension. A–C Baseline blood pressure at 12-, 24-, and 36-month. D–F Antihypertensive effect of RDN on blood pressure at 12-, 24-, and 36-month
See this image and copyright information in PMC

References

    1. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, De Palma SM, Gidding S, Jamerson KA, Jones DW, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269–1324. doi: 10.1161/HYP.0000000000000066. - DOI - PubMed
    1. Smith SM, Gurka MJ, Winterstein AG, Pepine CJ, Cooper-DeHoff RM. Incidence, prevalence, and predictors of treatment-resistant hypertension with intensive blood pressure lowering. J Clin Hypertens. 2019;21(6):825–34. doi: 10.1111/jch.13550. - DOI - PMC - PubMed
    1. Kaczmarski KR, Sozio SM, Chen J, Sang Y, Shafi T. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES) BMC Nephrol. 2019;20(1):138. doi: 10.1186/s12882-019-1315-0. - DOI - PMC - PubMed
    1. Lay-Flurrie SL, Sheppard JP, Stevens RJ, Mallen C, Heneghan C, Hobbs FDR, Williams B, Mant J, McManus RJ. Impact of changes to national hypertension guidelines on hypertension management and outcomes in the United Kingdom. Hypertension. 2020;75(2):356–64. doi: 10.1161/HYPERTENSIONAHA.119.13926. - DOI - PMC - PubMed
    1. Sinnott S-J, Smeeth L, Williamson E, Douglas IJ. Trends for prevalence and incidence of resistant hypertension: population based cohort study in the UK 1995–2015. BMJ. 2017;358:3984. doi: 10.1136/bmj.j3984. - DOI - PMC - PubMed

Publication types

Substances